Biktarvy is indicated for the treatment of human immunodeficiency virus1 (HIV-1)infection in adults without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir
Common side effects(may affect up to 1 in 10people)•depression•abnormal dreams•headache•dizziness•diarrhoea•feeling sick (nausea)•tiredness (fatigue)Uncommon side effects(may affect up to 1 in 100people)•anaemia•vomiting•stomach pain•problems with digestion resulting in discomfort after meals (dyspepsia)•wind (flatulence) 6•swelling of the face, lips, tongue or throat(angioedema)•itching(pruritus)•rash•hives (urticaria)•joint pain (arthralgia)•suicidal behaviour•anxiety•sleep disorders
Biktarvy is indicated for the treatment of human immunodeficiency virus 1 (HIV-1) infection in adults without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir.
Diabetes is a disease affecting over 29.1 Million Americans – approximately 9.3% of the population in America. This is according to the American diabetes Association Statistics report from June 2014. Did you know that Diabetes
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.